Delivery Order SPE2DB24D2011-SPE2DB25FBRWM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,535.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for cholesterol management. This firm fixed-price delivery order, issued on September 9, 2025, with completion targeted for September 10, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $40,818.37 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a specialized pharmaceutical product used in cardiovascular disease management. This competitively awarded, firm fixed price contract was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $45,894.09 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on August 18, 2025, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $12,145.84 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a prescription medication used to manage cholesterol levels. The contract, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,562.13 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cholesterol management. The contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,203.06 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency awarded a delivery order valued at $9,088.12 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a prescription medication used to treat high cholesterol. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded without a set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,742.98 for Repatha 140 mg/ml SureClick pharmaceutical supplies. The contract, executed on May 20, 2025, with an ultimate completion date of May 21, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $22,253.67 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick, a prescription medication used to treat high cholesterol. The contract, which is not set-aside and operates under firm fixed-price terms, was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania will serve as the place of performance for this delivery...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRWMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $40,099.62 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for cholesterol management. This firm fixed-price delivery order, effective September 17, 2025, with completion scheduled for September 18, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has established itself as a major vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract structure demonstrates the DLA's reliance on AmerisourceBergen as a prime pharmaceutical vendor, with the company maintaining capability to fulfill federal medical supply requirements across multiple therapeutic domains for defense health customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.1k | 9/17/25 |